Renal Dialysis Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Renal Dialysis Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
Summary
GlobalData's Medical Devices sector report, “Renal Dialysis Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Renal Dialysis Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Renal dialysis equipment is intended to provide an artificial replacement for lost kidney function due to renal failure.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Renal Dialysis Equipment under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Renal Dialysis Equipment and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Renal Dialysis Equipment under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Renal Dialysis Equipment Overview
4 Products under Development
4.1 Renal Dialysis Equipment - Pipeline Products by Stage of Development
4.2 Renal Dialysis Equipment - Pipeline Products by Segment
4.3 Renal Dialysis Equipment - Pipeline Products by Territory
4.4 Renal Dialysis Equipment - Pipeline Products by Regulatory Path
4.5 Renal Dialysis Equipment - Pipeline Products by Estimated Approval Date
6.110 Zylox-Tonbridge Medical Technology Co Ltd Company Overview
6.110.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
7 Renal Dialysis Equipment- Recent Developments
7.1 Jun 20, 2023: Breakthrough Study Demonstrates that High-Dose Hemodiafiltration Treatment for Kidney Failure Patients Significantly Reduces Mortality Rates
7.2 Jun 09, 2023: Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2023
7.3 Jun 05, 2023: Renalytix to Report Third Quarter Fiscal Year 2023 Financial Results on June 9
7.4 May 15, 2023: SeaStar Medical reports Q1 2023 financial results and provides a business update
7.5 May 12, 2023: Marubun announces summary of consolidated financial results for the fiscal year ended March 31, 2023
7.6 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
7.7 May 10, 2023: Nephros announces results for quarter ended March 31, 2023
7.8 May 09, 2023: Redsense Medical announces interim report Q1 January - March, 2023
7.9 May 04, 2023: Teleflex reports first quarter financial results and full year 2023 outlook
7.10 Apr 26, 2023: Merit Medical reports results for first quarter March 31, 2023
7.11 Apr 20, 2023: Teleflex announces first quarter 2023 earnings conference call information
7.12 Apr 12, 2023: Medtronic has a layoff in California
7.13 Apr 06, 2023: Merit Medical Systems to Announce First Quarter 2023 Results on April 26, 2023
7.14 Apr 03, 2023: Medtronic and DaVita launch new company to focus on kidney health
7.15 Mar 29, 2023: Baxter to Host Annual Meeting of Stockholders in Virtual Format
7.16 Mar 22, 2023: Renalytix to Report Second Quarter and First Half Fiscal Year 2023 Financial Results on March 30
7.17 Mar 16, 2023: Medtronic joins in $25M funding round for home monitoring company
7.18 Mar 09, 2023: Somatus expands partnership with Inova to further enhance Care and Improve Outcomes for Patients
7.19 Mar 08, 2023: Nephros Announces Fourth Quarter and Fiscal Year 2022 Financial Results
7.20 Mar 08, 2023: UCSF Health Appoints Two Prominent Healthcare Executives to Senior Leadership Positions
7.21 Mar 08, 2023: Asahi Kasei Corp. Announces Change in Representative Directors
7.22 Feb 23, 2023: Teleflex Reports Fourth Quarter and Full Year 2022 Financial Results
7.23 Feb 22, 2023: Nephros Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call
7.24 Feb 21, 2023: Teleflex to Present at the 44th Annual Raymond James Institutional Investors Conference
7.25 Feb 14, 2023: Marubun Notice of Revisions of Consolidated Financial Results Forecast for the Fiscal Year Ending March 31, 2023 and Dividend Forecast
7.26 Feb 13, 2023: Rockwell Medical and Concerto Renal Services establish new three-year, multi-million dollar product purchase agreement
7.27 Feb 10, 2023: Groundbreaking USask research identifies key blood protein target for improving dialysis
7.28 Feb 09, 2023: Teleflex Announces Fourth Quarter 2022 Earnings Conference Call Information
7.29 Feb 09, 2023: Baxter Reports Fourth-Quarter and Full-Year 2022 Results
7.30 Feb 08, 2023: Asahi Kasei Announces Consolidated Results for 1st to 3rd Quarter Fiscal 2022
7.31 Feb 07, 2023: JMS Co Announces Financial Results for the 3rd Quarter of FYE March 2023
7.32 Feb 03, 2023: Merit Medical Systems to Announce Fourth Quarter and Year End 2022 Results and Issue Fiscal Year 2023 Guidance on February 22, 2023
7.33 Jan 31, 2023: Marubun Corporation Announces Summary of Consolidated Financial Results for the Nine Months Ended December 31, 2022
7.34 Jan 20, 2023: Healthcare Workers File Petition Asking FDA to Recall Fresenius Dialysis Machines to Protect Patients
7.35 Jan 09, 2023: Outset Medical Reports Expected Fourth Quarter and Full Year 2022 Revenue, Provides 2023 Revenue and non-GAAP Gross Margin Guidance
7.36 Jan 09, 2023: Satellite Healthcare Appoints Board of Directors Chair and Vice Chair
7.37 Dec 13, 2022: Rockwell Medical Begins Selling its Hemodialysis Concentrates Products to New Clinics in Minnesota with its Largest Customer
7.38 Dec 07, 2022: Cook Medical welcomes Dr. John A. Kaufman as Chief Medical Officer
7.39 Nov 23, 2022: Medtronic Reports Quarterly Earnings
7.40 Nov 22, 2022: Renalytix to Report Financial Results for First Quarter Fiscal Year 2023 on November 30
7.41 Nov 22, 2022: Medtronic reports second quarter fiscal 2023 financial results
7.42 Nov 22, 2022: Fresenius Places Bonds With a Volume of EUR1 Billion
7.43 Nov 15, 2022: Medtronic Set to Announce Earnings on Tuesday
7.44 Nov 14, 2022: Rockwell Medical Provides Business Strategy Update and Announces Third Quarter 2022 Financial and Operational Results
7.45 Nov 10, 2022: Study examines symptom burden before and after starting dialysis in older adults
7.46 Nov 09, 2022: Redsense Medical Interim Report Q3 - July - September, 2022
7.47 Nov 09, 2022: Redsense Medical Announces Interim Report Q3 – July – September, 2022
7.48 Nov 09, 2022: Asahi Kasei announces Consolidated Results for 1st and 2nd Quarter Fiscal 2022
7.49 Nov 04, 2022: JMS Co. Announces Consolidated Financial Highlights for the Interim Period Ended September 2022
7.50 Nov 04, 2022: Poly Medicure Announces Unaudited Standalone & Consolidated Financial Results for the Quarter Ended 0n 30th Sep. 2022
7.51 Nov 02, 2022: Nephros Announces Results for Quarter Ended September 30, 2022
7.52 Oct 31, 2022: Renalytix Reports Full Year Fiscal 2022 Results
7.53 Oct 27, 2022: Teleflex Reports Third Quarter Financial Results And Full Year Outlook
7.54 Oct 27, 2022: Satellite Healthcare introduces an innovative care model for people newly diagnosed with kidney disease requiring dialysis
7.55 Oct 26, 2022: Outset Medical to Report Third Quarter 2022 Financial Results Tuesday, November 8, 2022
7.56 Oct 13, 2022: Teleflex Announces Third Quarter 2022 Earnings Conference Call Information
7.57 Oct 13, 2022: Merit Medical Systems to Announce Third Quarter Results on October 26, 2022
7.58 Oct 12, 2022: Nephros to Present at LD Micro Main Event XV
7.59 Sep 29, 2022: UMC Health System and Dialyze direct collaborate to bring onsite dialysis options to Lubbock County and West Texas
7.60 Sep 26, 2022: Satellite Healthcare joins other non-profit partners to open first dialysis center in Hawai‘i focused on higher-risk patients
7.61 Sep 26, 2022: Miromatrix CEO Jeff Ross to Present at the Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event
7.62 Sep 20, 2022: Miromatrix CEO Jeff Ross to Present at the Bioregate European Regenerative Medicine Forum
7.63 Sep 15, 2022: New article brings forward support for home dialysis in connection with comorbidities
7.64 Sep 07, 2022: Baxter to Host Third-Quarter 2022 Financial Results Conference Call for Investors
7.65 Sep 07, 2022: Medtronic to appear at September investor conferences
7.66 Aug 30, 2022: Outset Medical to Present at the 20th Annual Morgan Stanley Global Healthcare Conference
7.67 Aug 25, 2022: Somatus Names New Medical Executive to Direct the Delivery of World-Class Kidney Care
7.68 Aug 23, 2022: Medtronic reports first quarter fiscal 2023 financial results
7.69 Aug 23, 2022: Medtronic Announces Quarterly Earnings Results
7.70 Aug 17, 2022: Mr. Rom Mendel appointed new CEO of Optinova
7.71 Aug 16, 2022: Boston Scientific Announces Upcoming Conference Schedule
7.72 Aug 15, 2022: Miromatrix Reports Second Quarter 2022 Results and Provides Corporate Update
7.73 Aug 11, 2022: NanoVibronix announce quarter ended June 30, 2022
7.74 Aug 10, 2022: Nephros Announces Results for Quarter Ended June 30, 2022
7.75 Aug 05, 2022: JMS Co. Announces Consolidated Financial Highlights for the Interim Period Ended June 2022
7.76 Aug 04, 2022: Poly Medicure announces Financial results For The Quarter Ended 30Th June 2022
7.77 Aug 01, 2022: Outset Medical Reports Second Quarter 2022 Financial Results and Provides 2022 Guidance
7.78 Aug 01, 2022: Outset Medical Resumes Shipment of Tablo Systems for Home Use Reports Second Quarter 2022 Financial Results and Provides 2022 Guidance
7.79 Aug 01, 2022: Miromatrix to Report Second Quarter 2022 Financial Results
7.80 Jul 27, 2022: Merit Medical Reports Results for Quarter Ended June 30, 2022
Table 49: Point of Care Generation 1 System - Product Status
Table 50: Point of Care Generation 1 System - Product Description
Table 51: Point of Care Generation 2 System - Product Status
Table 52: Point of Care Generation 2 System - Product Description
Table 53: PrisMax 2 System - Product Status
Table 54: PrisMax 2 System - Product Description
Table 55: Baxter International Inc - Ongoing Clinical Trials Overview
Table 56: oXiris - A Pilot Multicentre Open-Label Randomized Controlled Trial During Treatment for Acute Kidney Injury in Critically Ill Patients with Septic Shock Comparing Two Haemofilter Membrane Devices, The An69st and the Newly Available Oxiris Haemofiltration Membrane for Early Resolution of Shock As Well As Other Clinical and Technical Performance Outcomes
Table 57: oXiris - A Randomized, Controlled Trial to Evaluate Efficacy and Safety of a Highly Selective Semipermeable Membrane (AN-69 Oxiris) in Comparison with a Semi Selective Semipermeable Membrane (Standard AN-69) in COVID-19 Associated Acute Kidney Injury: oXAKI-COV Study
Table 58: oXiris - Antibiotic Plasma Concentrations During Continuous Renal Replacement Therapy with a High Adsorption Membrane (oXiris)
Table 59: oXiris - Clinical Study of Microcirculatory Parameters in Septic/Septic Shock Patients Treated with Oxiris Filter
Table 60: oXiris - Effect of Oxiris Membrane on Microcirculation Following Cardiac Surgery Under Cardiopulmonary Bypass: A Pilot Prospective Monocentric Study (Oxicard Study)
Table 61: oXiris - Effects of Removal of Endotoxin, Cytokines, and Uremic Toxins Using Blood Purification on Patients with Severe Septic Shock
Table 62: oXiris - Endotoxins and Cytokines Removal During Continuous Hemofiltration with oXiris
Table 63: oXiris - Evaluation of Oxiris Membrane as a Treatment for Ischemia-reperfusion Syndrome in Cardiogenic Shock Treated with Extracorporeal Life Support (ECMO/ECLS): A Randomized Pilot Study ECMORIX
Table 64: oXiris - Real-time Monitoring of Hemodynamic Stability in Septic Shock Patients Undergoing Continuous Renal Replacement Therapy: Propensity Score-matched Comparison Between oXiris and Polysulfone Membranes
Table 65: oXiris - Renal Replacement Therapy with a Cytokine Absorption Filter (oXiris) in Patients with Septic Shock: a Case-control Study Nested in a Cohort
Table 66: oXiris - The Effect of a Hemoperfusion with Polyethyleneimine-coated Membrane Filter (Oxiris) in Patients with Septic Shock: A Multicenter Randomized Controlled Trial
Table 67: oXiris - The Effects of Extracorporeal Blood Purification (oXiris) in Patients with Cardiogenic Shock Requiring VA-ECMO: A Prospective, Open-label, Randomized Controlled Pilot Study
Table 68: oXiris - The Effects of oXiris on Systemic Inflammation, Endothelial Dysfunction and Volume Control in Cardiac Surgery Patients Undergoing Cardiopulmonary Bypass
Table 69: oXiris - The Efficacy of Different Mode of Blood Purification in Septic Children